ANIXA BIOSCIENCES, INC. Total Liabilities and Equity
ANIXA BIOSCIENCES, INC. (ANIX) had Total Liabilities and Equity of $15.07 million as of 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-09-09
- 2026-07-31: Liabilities and Equity $15.07M.
- 2026-04-30: Liabilities and Equity $14.87M.
- 2026-01-31: Liabilities and Equity $15.23M.
- 2025-10-31: Liabilities and Equity $16.08M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-07-31 | $15.07M 10-Q · filed 2026-09-09 | |
| 2026-04-30 | $14.87M 10-Q · filed 2026-06-10 | |
| 2026-01-31 | $15.23M 10-Q · filed 2026-03-09 | |
| 2025-10-31 | $16.08M 10-Q · filed 2026-09-09 | |
| 2025-07-31 | $17.65M 10-Q · filed 2025-09-10 | |
| 2025-04-30 | $16.98M 10-Q · filed 2025-05-28 | |
| 2025-01-31 | $18.91M 10-Q · filed 2025-03-11 | |
| 2024-10-31 | $21.59M 10-K · filed 2026-01-12 | |
| 2024-07-31 | $22.91M 10-Q · filed 2024-09-06 | |
| 2024-04-30 | $24.36M 10-Q · filed 2024-06-04 | |
| 2024-01-31 | $25.37M 10-Q · filed 2024-03-12 | |
| 2023-10-31 | $25.52M 10-K · filed 2025-01-10 | |
| 2023-07-31 | $26.58M 10-Q · filed 2023-09-06 | |
| 2023-04-30 | $27.60M 10-Q · filed 2023-06-14 | |
| 2023-01-31 | $28.31M 10-Q · filed 2023-03-17 | |
| 2022-10-31 | $30.41M 10-K · filed 2024-01-16 | |
| 2022-07-31 | $32.56M 10-Q · filed 2022-09-09 | |
| 2022-04-30 | $32.80M 10-Q · filed 2022-06-10 | |
| 2022-01-31 | $35.24M 10-Q · filed 2022-03-11 | |
| 2021-10-31 | $36.26M 10-K · filed 2023-01-04 | $36.26M 10-K · filed 2022-01-04 |
| 2021-07-31 | $37.06M 10-Q · filed 2021-09-01 | |
| 2021-04-30 | $38.50M 10-Q · filed 2021-06-10 | |
| 2021-01-31 | $14.60M 10-Q · filed 2021-03-11 | |
| 2020-10-31 | $9.45M 10-K · filed 2022-01-04 | |
| 2020-07-31 | $9.36M 10-Q · filed 2020-09-08 | |
| 2020-04-30 | $5.92M 10-Q · filed 2020-06-09 | |
| 2020-01-31 | $6.16M 10-Q · filed 2020-03-09 | |
| 2019-10-31 | $6.29M 10-K · filed 2021-01-07 | |
| 2019-07-31 | $6.84M 10-Q · filed 2019-09-06 | |
| 2019-04-30 | $7.77M 10-Q · filed 2019-06-12 | |
| 2019-01-31 | $6.47M 10-Q · filed 2019-03-13 | |
| 2018-10-31 | $6.45M 10-K · filed 2020-01-09 | |
| 2018-07-31 | $7.29M 10-Q · filed 2018-09-07 | |
| 2018-04-30 | $7.36M 10-Q · filed 2018-06-11 | |
| 2018-01-31 | $7.49M 10-Q · filed 2018-03-09 | |
| 2017-10-31 | $8.81M 10-K · filed 2019-01-11 | |
| 2017-07-31 | $8.41M 10-Q · filed 2017-09-08 | |
| 2017-04-30 | $7.25M 10-Q · filed 2017-05-26 | |
| 2017-01-31 | $4.22M 10-Q · filed 2017-03-16 | |
| 2016-10-31 | $5.63M 10-K · filed 2018-01-09 | |
| 2016-07-31 | $6.32M 10-Q · filed 2016-08-19 | |
| 2016-04-30 | $7.21M 10-Q · filed 2016-05-20 | |
| 2016-01-31 | $8.65M 10-Q · filed 2016-02-19 | |
| 2015-10-31 | $9.34M 10-K · filed 2016-12-08 | |
| 2015-07-31 | $10.28M 10-Q · filed 2015-08-18 | |
| 2015-04-30 | $11.13M 10-Q · filed 2015-05-22 | |
| 2015-01-31 | $13.27M 10-Q · filed 2015-03-09 | |
| 2014-10-31 | $9.06M 10-K · filed 2015-12-23 | |
| 2014-07-31 | $13.40M 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $10.50M 10-Q · filed 2014-06-16 | |
| 2014-01-31 | $10.33M 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $5.44M 10-K · filed 2015-01-29 | |
| 2013-07-31 | $5.31M 10-Q/A · filed 2013-09-20 | |
| 2013-04-30 | $7.35M 10-Q/A · filed 2013-06-19 | |
| 2013-01-31 | $7.52M 10-Q/A · filed 2013-03-25 | |
| 2012-10-31 | $5.66M 10-K/A · filed 2014-01-17 | |
| 2012-07-31 | $5.89M 10-Q · filed 2012-09-14 | |
| 2012-04-30 | $6.79M 10-Q · filed 2012-06-14 | |
| 2012-01-31 | $8.03M 10-Q · filed 2012-03-16 | |
| 2011-10-31 | $8.65M 10-K · filed 2013-01-29 | |
| 2011-07-31 | $10.17M 10-Q/A · filed 2011-10-14 | |
| 2010-10-31 | $10.05M 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |